Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CAN-FITE-BIOPHARMA-LTD-56536764/news/Namodenoson-Treatment-for-Pancreatic-and-Liver-Cancer-Data-will-be-Discussed-in-Out-licensing-and-D-46139438/?utm_source=whatsapp&utm_medium=social&utm_campaign=share